OKT3 prophylaxis in kidney transplant recipients: drug monitoring by flow cytometry

Transplant Proc. 1996 Dec;28(6):3214-6.
No abstract available

Publication types

  • Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antigens, CD / blood
  • CD3 Complex / blood
  • Drug Monitoring / methods
  • Flow Cytometry / methods
  • Graft Rejection / immunology
  • Graft Rejection / prevention & control*
  • Humans
  • Immunosuppression Therapy / methods
  • Immunosuppressive Agents / blood
  • Immunosuppressive Agents / therapeutic use*
  • Kidney Transplantation / immunology*
  • Muromonab-CD3 / blood
  • Muromonab-CD3 / therapeutic use*
  • T-Lymphocyte Subsets / immunology

Substances

  • Antigens, CD
  • CD3 Complex
  • Immunosuppressive Agents
  • Muromonab-CD3